These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3409395)

  • 1. A kinetic study on drug distribution: furosemide in rats.
    Kitani M; Ozaki Y; Katayama K; Kakemi M; Koizumi T
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):1053-62. PubMed ID: 3409395
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of furosemide distribution in the rat].
    Prandota J; Pruitt AW
    Pediatr Pol; 1987 Aug; 62(8):575-83. PubMed ID: 3431969
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic, biliary excretion, and metabolic studies of 14C-furosemide in the rat.
    Prandota J; Pruitt AW
    Xenobiotica; 1991 Jun; 21(6):725-36. PubMed ID: 1949904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetics of furosemide elimination with the bile and its metabolism in rats].
    Prandota J; Pruitt AW
    Pediatr Pol; 1987 Aug; 62(8):584-94. PubMed ID: 3431970
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of absorption furosemide prodrugs: synthesis, in vitro and in vivo evaluation.
    Prandi C; Fagiolino P; Manta E; Llera LD; Aiache JM; Couquelet J
    Farmaco; 1992 Feb; 47(2):249-63. PubMed ID: 1510797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceutic evaluation of furosemide as a potential candidate for a modified release peroral dosage form.
    Ritschel WA; Menon A; Sakr A
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):629-36. PubMed ID: 1787770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of route of administration on the relative efficacy and potency of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol HCl (MK447) and furosemide.
    Johnston PA; Leszczynska K; Yochim C; Kau ST
    Methods Find Exp Clin Pharmacol; 1990 Sep; 12(7):481-6. PubMed ID: 2087148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced absorption of oral furosemide by bile juice in rats.
    Kim EJ; Han KS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1999; 104(1):107-10. PubMed ID: 10604283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection by magnesium of renal calcinosis in furosemide-treated weanling rats with moderate magnesium deficiency.
    Caddell JL
    Biol Neonate; 1985; 48(1):49-58. PubMed ID: 4041503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a hepatoprotective agent, YH-439, on the pharmacokinetics of furosemide and azosemide in rats.
    Kim SH; Park KJ; Yoon WH; Lee JW; Kim ND; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):233-44. PubMed ID: 8832915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects on the pharmacokinetics of furosemide after acute exposure to high altitude at 4010 meters in rats].
    Li WB; Wang R; Xie H; Zhang JH; Xie XH; Wu XY; Jia ZP
    Yao Xue Xue Bao; 2012 Dec; 47(12):1718-21. PubMed ID: 23460981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Both in vitro and in vivo Kinetics by SLNs Induced Transdermal System of Furosemide: A Novel Approach.
    Mannam R; Yallamalli IM
    Recent Pat Drug Deliv Formul; 2017; 11(3):187-197. PubMed ID: 29189185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
    Yang KH; Choi YH; Lee U; Lee JH; Lee MG
    J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturable first-pass kinetics, plasma protein binding, and the furosemide intricacies.
    Keller F
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S24-6. PubMed ID: 7781201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs.
    Nkansah P; Antipas A; Lu Y; Varma M; Rotter C; Rago B; El-Kattan A; Taylor G; Rubio M; Litchfield J
    J Control Release; 2013 Jul; 169(1-2):150-61. PubMed ID: 23570985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antidiuretic hormone in the attenuated furosemide response observed during indomethacin administration.
    Kirchner KA
    J Lab Clin Med; 1988 Feb; 111(2):237-43. PubMed ID: 3339276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model based population PK-PD analysis of furosemide for BP lowering effect: A comparative study in primary and secondary hypertension.
    Shukla M; Ibrahim MMA; Jain M; Jaiswal S; Sharma A; Hanif K; Lal J
    Eur J Pharm Sci; 2017 Nov; 109():253-261. PubMed ID: 28821435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models for predicting potency of oral sustained-release adhesive microspheres in humans.
    Nagahara N; Akiyama Y; Higaki K; Kimura T
    Int J Pharm; 2007 Feb; 331(1):46-53. PubMed ID: 17098383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Features of the pharmacodynamics and pharmacokinetics of furosemide upon long-term administration in rats].
    Briukhanov VM; Zverev IaF; Lampatov VV; Zharikov AIu
    Eksp Klin Farmakol; 2007; 70(2):33-6. PubMed ID: 17523448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanized thymidine kinase-NOG mice can be used to identify drugs that cause animal-specific hepatotoxicity: a case study with furosemide.
    Xu D; Michie SA; Zheng M; Takeda S; Wu M; Peltz G
    J Pharmacol Exp Ther; 2015 Jul; 354(1):73-8. PubMed ID: 25962391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.